Vandervoort Adam C exercised Options covering 14,928 Teladoc shares on September 1, then sold 7,573 shares at $6.30 each on September 2. Afterward, reported ownership stood at 117,616 shares and 2,553 derivative securities, giving investors the latest disclosed snapshot of his holdings.
Key Highlights
- Vandervoort Adam C held 125,189 Teladoc shares after exercising the options.
- The option exercises were recorded at $0 per share on September 1, 2026.
- Vandervoort Adam C held 2,553 derivative securities after the exercises.
Vandervoort Adam C exercised options for 14,928 shares of Teladoc Health, Inc (NYSE: TDOC). on September 1, 2026, then sold 7,573 shares at $6.30 per share on September 2, 2026. The exercise transactions were recorded at $0 per share.
$6.30 Sale Follows Option Exercises
Following the option exercises, Vandervoort Adam C reported ownership of 125,189 Teladoc shares. The exercises covered derivative securities and were recorded through separate transactions using SEC transaction code M. The subsequent share sale used SEC transaction code S and was completed at $6.30 per share. After that transaction, reported share ownership was 117,616. Vandervoort Adam C also reported ownership of 2,553 derivative securities after the option exercises, with those exercises recorded on September 1, 2026.
FAQs
Q: What did Vandervoort Adam C do in the Teladoc insider transaction?
A: Vandervoort Adam C exercised options for 14,928 Teladoc shares on September 1, 2026. He sold 7,573 shares at $6.30 per share on September 2, 2026.
Q: How many Teladoc shares did Vandervoort Adam C own after the sale?
A: Vandervoort Adam C reported ownership of 117,616 Teladoc shares after selling 7,573 shares. The reported sale price was $6.30 per share.
Q: How many derivative securities did Vandervoort Adam C hold?
A: Vandervoort Adam C reported owning 2,553 derivative securities after exercising the options. The option exercises were recorded at $0 per share on September 1, 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.